Announce Date | 05/28/2025 |
EPS Normalized Actual | $0.78 (Beat by $0.05) |
EPS GAAP Actual | $0.78 (Beat by $0.05) |
Revenue Actual | $0.332645B |
Revenue Surprise | Beat by $332.645M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $1.12901 |
EPS GAAP Estimate | $1.12901 |
Revenue Estimate | $0.348642317B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Mar 2030 | 0 | INF | 0 | 0 | 0 |
Mar 2029 | 5.87378 | 22.04 | 5.59224 | 6.09975 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.17 | 0.17 | 0.332645B | 3.46% | 332.65M |
FQ4 2024 (Dec 2024) | 0.63 | 0.63 | 0.35532B | 23.75% | 355.32M |
FQ3 2024 (Sep 2024) | 0.34 | 0.34 | 0.301075B | 28.42% | 301.08M |
FQ2 2024 (Jun 2024) | 0.85 | 0.85 | 0.324477B | 33.33% | 324.48M |
FQ1 2024 (Mar 2024) | 0.26 | 0.26 | 0.321143B | 41.66% | 321.14M |
FQ4 2023 (Dec 2023) | 0.49 | 0.49 | 0.270943B | 100% | 270.94M |
FQ3 2023 (Sep 2023) | 0.61 | 0.61 | 0.215507B | 100% | 215.51M |
FQ2 2023 (Jun 2023) | 0.98 | 0.98 | 0.216339B | 100% | 216.34M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
1.12901
Consensus Revenue Estimates
0.348642317B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.19788 | -- | 1.08037 | 1.30833 | 14 |
FQ3 2027 (Sep 2027) | 1.01192 | -- | 0.91265 | 1.10523 | 7 |
FQ2 2027 (Jun 2027) | 1.1562 | -- | 1.04278 | 1.26281 | 7 |
FQ1 2027 (Mar 2027) | 1.23223 | -- | 1.18458 | 1.27096 | 4 |
FQ4 2026 (Oct 2026) | 0.95158 | -- | 0.91657 | 0.993 | 9 |
FQ3 2026 (Jul 2026) | 0.98294 | -- | 0.94678 | 1.02572 | 9 |
FQ2 2026 (Jun 2026) | 0.98294 | -- | 0.94493 | 1.01383 | 4 |
FQ1 2026 (Mar 2026) | 0.50439 | 66.3 | 0.48285 | 0.52596 | 4 |
FQ4 2025 (Oct 2025) | 1.01504 | 37.93 | 0.9777 | 1.05922 | 6 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.57B | -- | 0.52B | 0.61B | 7 |
FQ3 2027 (Sep 2027) | 0.52B | -- | 0.48B | 0.55B | 7 |
FQ2 2027 (Jun 2027) | 0.53B | -- | 0.49B | 0.56B | 7 |
FQ1 2027 (Mar 2027) | 0.49B | -- | 0.48B | 0.51B | 5 |
FQ4 2026 (Oct 2026) | 0.37B | -- | 0.36B | 0.38B | 8 |
FQ3 2026 (Jul 2026) | 0.38B | -- | 0.37B | 0.39B | 5 |
FQ2 2026 (Jun 2026) | 0.38B | -- | 0.37B | 0.39B | 5 |
FQ1 2026 (Mar 2026) | 0.38B | 12.42 | 0.37B | 0.39B | 9 |
FQ4 2025 (Oct 2025) | 0.34B | -6.05 | 0.33B | 0.35B | 6 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.17 | 0.17 | 100% | |
FQ4 2024 (Dec 2024) | 0.63 | 0.63 | 100% | |
FQ3 2024 (Sep 2024) | 0.34 | 0.34 | 100% | |
FQ2 2024 (Jun 2024) | 0.85 | 0.85 | 100% | |
FQ1 2024 (Mar 2024) | 0.26 | 0.26 | 100% | |
FQ4 2023 (Dec 2023) | 0.49 | 0.49 | 100% | |
FQ3 2023 (Sep 2023) | 0.61 | 0.61 | 100% | |
FQ2 2023 (Jun 2023) | 0.98 | 0.98 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $0.33B | $332.65M | 100% |
FQ4 2024 (Dec 2024) | $0B | $0.36B | $355.32M | 100% |
FQ3 2024 (Sep 2024) | $0B | $0.3B | $301.08M | 100% |
FQ2 2024 (Jun 2024) | $0B | $0.32B | $324.48M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.32B | $321.14M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.27B | $270.94M | 100% |
FQ3 2023 (Sep 2023) | $0B | $0.22B | $215.51M | 100% |
FQ2 2023 (Jun 2023) | $0B | $0.22B | $216.34M | 100% |